Inhibitors of SAMHD1 Obtained from Chemical Tethering to the Guanine Antiviral Acyclovir
Biochemistry · 2025
DOI: 10.1021/acs.biochem.4c00854 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry, 2025. Verfasst von Matthew Egleston und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, 725 North Wolfe Street, Baltimore, Maryland 21205, Un…. Hauptthemen laut MEDLINE: SAM Domain and HD Domain-Containing Protein 1, Acyclovir, Antiviral Agents, Enzyme Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIGMS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Sterile alpha motif histidine-aspartate domain protein 1 (SAMHD1) is an enzyme with diverse activities. Its dNTPase activity degrades all canonical dNTPs and many anticancer nucleoside drugs, while its single-stranded nucleic acid binding activity promotes DNA repair and RNA homeostasis in cells. These functions require guanine nucleotide binding to a specific allosteric site (A1) on the enzyme. We previously described how the activities of SAMHD1 could be inhibited in vitro with fragment-based inhibitor design, using dGMP as a targeting fragment for the A1 site. However, these dGMP-tethered inhibitors had poor cell permeability due to the charged guanine monophosphate group. Here, we describe a new approach where the amino form of the guanine acyclic nucleoside acyclovir (NH 2 -ACV) is used as the targeting fragment, allowing facile coupling to activated carboxylic acids (R–COOH), either directly or using linkers. This approach generates a neutral amide instead of charged monophosphate attachment points. High-throughput screening of a ∼375 compound carboxylic acid library identified two compounds ( 8, 11 ) with similar micromolar affinities for SAMHD1. Compound 11 was obtained by direct coupling to NH 2 -ACV, while compound 8 used a five-carbon linker. Both inhibitors had the same dibromonaphthol component from the carboxylic acid library screen. A crystal structure of a complex between SAMHD1 and 8, combined with computational models of bound 11, suggest how the dibromonaphthol promotes binding. The findings establish that guanine-based inhibitors targeting the A1 site do not require nucleotide or cyclic nucleoside structural elements. This guanine site targeting strategy is highly amenable to further chemical optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, 725 North Wolfe Street, Baltimore, Maryland 21205, United States.
- Department of Chemistry, Johns Hopkins University, 3400 North Charles Street, Baltimore, Maryland 21218, United States.
- Department of Biophysics & Biophysical Chemistry, Johns Hopkins University School of Medicine, 725 North Wolfe Street, Baltimore, Maryland 21205, United States.
ORCID-Profile: Matthew Egleston, Marc M Greenberg, James T Stivers
Förderung
- NIH HHS
- NIGMS NIH HHS
- NCI NIH HHS
- National Cancer Institute
- National Institute of General Medical Sciences
Zitieren
APA
Egleston, M., Bhat, S., Howlader, A. H., Bianchet, M. A., Liu, Y., Lopez Rovira, L. M., Smith, B., Greenberg, M. M., & Stivers, J. T. (2025). Inhibitors of SAMHD1 Obtained from Chemical Tethering to the Guanine Antiviral Acyclovir. Biochemistry. https://doi.org/10.1021/acs.biochem.4c00854
Vancouver
Egleston M, Bhat S, Howlader AH, Bianchet MA, Liu Y, Lopez Rovira LM, et al. Inhibitors of SAMHD1 Obtained from Chemical Tethering to the Guanine Antiviral Acyclovir. Biochemistry. 2025. doi:10.1021/acs.biochem.4c00854
BibTeX
@article{Egleston2025,
author = {Egleston, Matthew and Bhat, Shridhar and Howlader, A Hasan and Bianchet, Mario A and Liu, Yi and Lopez Rovira, Laura Maria and Smith, Brandon and Greenberg, Marc M and Stivers, James T},
title = {Inhibitors of SAMHD1 Obtained from Chemical Tethering to the Guanine Antiviral Acyclovir},
journal = {Biochemistry},
year = {2025},
doi = {10.1021/acs.biochem.4c00854}
}
EUVIMED